← Back to Screener
LeonaBio, Inc. Common Stock (LONA)
Price$8.63
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)90.72%
Price vs S&P 500 (4W)-11.28%
VGM Score80.57
Market Capitalization$84.73M
All Metrics
Book Value / Share (Quarterly)$5.25
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-5.53
Price vs S&P 500 (YTD)7.77%
EPS (TTM)$-20.70
10-Day Avg Trading Volume0.05M
EPS Excl Extra (TTM)$-20.70
EPS (Annual)$-24.70
ROI (Annual)-380.03%
Cash / Share (Quarterly)$7.20
ROA (Last FY)-114.60%
EBITD / Share (TTM)$-13.53
ROE (5Y Avg)-148.87%
Cash Flow / Share (Annual)$-4.90
P/B Ratio1.72x
P/B Ratio (Quarterly)1.96x
Net Income / Employee (Annual)$-5,558,400
Net Interest Coverage (TTM)-18.57x
ROA (TTM)-225.74%
EPS Incl Extra (Annual)$-24.70
Current Ratio (Annual)1.88x
Quick Ratio (Quarterly)10.15x
3-Month Avg Trading Volume0.06M
52-Week Price Return216.49%
Revenue / Employee (TTM)$0
52-Week High$14.21
EPS Excl Extra (Annual)$-24.70
26-Week Price Return104.30%
Quick Ratio (Annual)1.86x
13-Week Price Return57.69%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)10.38x
Enterprise Value$51.90M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$9.46
3-Month Return Std Dev119.11%
Net Income / Employee (TTM)$-6,811,300
ROE (Last FY)-380.03%
EPS Basic Excl Extra (Annual)$-24.70
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-20.70
Receivables Turnover (Annual)0.00x
ROI (TTM)-381.01%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)188.34%
Year-to-Date Return19.15%
5-Day Price Return-8.05%
EPS Normalized (Annual)$-24.70
ROA (5Y Avg)-81.30%
Month-to-Date Return-5.45%
EBITD / Share (Annual)$-23.69
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-148.87%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-20.70
P/B Ratio (Annual)0.99x
Book Value / Share (Annual)$2.98
Price vs S&P 500 (13W)47.03%
Beta2.04x
Revenue / Share (TTM)$0.00
ROE (TTM)-381.01%
52-Week Low$2.73
mGradeA
vgmGradeA
Show chart for
Earnings Surprise History
Q1 26-1.73est. -2.55
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
2.29
4.00
4.00
4.00
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
LONALeonaBio, Inc. Common Stock | — | — | A | $8.63 |
| AMGNAmgen Inc | C | C | C | $338.22 |
| GILDGilead Sciences Inc | C | B | C | $128.99 |
| ARGXargenx SE American Depositary Shares | D | A | B | $813.14 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $155.99 |
| BIIBBiogen Inc. Common Stock | B | D | C | $195.96 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.45 |
| MRNAModerna, Inc. Common Stock | C | B | C | $49.06 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $165.11 |
| EXELExelixis Inc | C | B | B | $51.60 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | B | $301.82 |
About
LeonaBio Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for serious diseases with significant unmet medical needs. The company focuses on treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS), two conditions with limited existing treatment options. LeonaBio's pipeline targets patient populations facing critical therapeutic gaps and represents potential first-in-class or best-in-class opportunities.